Downregulation of GSDMC expression attenuates the proliferation of colorectal cancer cells, whereas overexpression of GSDMC contributes to its proliferation and tumorigenesis, implying that GSDMC has great potential as a therapeutic target for CRC [72]. The gene discussed is GSDMC; the disease is colorectal carcinoma.